Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of <i>MYCN</i> Amplification in Serum DNA Using Conventional Polymerase Chain Reaction

1 Jan 2016

Abstract excerpt

Neuroblastoma (NB) is the most common extra-cranial solid tumor of childhood and is characterized by a wide range of clinical behaviors. Amplification of MYCN is a well-known poor prognostic factor in NB patients. As the MYCN amplification status is usually tested using tumor specimens, lengthy and invasive procedures are unavoidable. To evaluate the possibility of detecting MYCN amplification without invasive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Neuroblastoma Research and Treatments
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27510381
DOI: 10.3346/jkms.2016.31.9.1392

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of <i>MYCN</i> Amplification in Serum DNA Using Conventional Polymerase Chain ReactionPMID 27510381Read ↗

Prediction of <i>MYCN</i> Amplification in Neuroblastoma Using Serum DNA and Real-Time Quantitative Polymerase Chain ReactionSemantic proximity Read ↗

A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patientsSemantic proximity Read ↗

MYCN protein stability is a better prognostic indicator in neuroblastomaSemantic proximity Read ↗

MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastomaSemantic proximity Read ↗

A systematic review of circulating-free MYCN amplification status as a noninvasive and prominent prognostic and recurrence monitoring indicator for neuroblastomaSemantic proximity Read ↗

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology GroupSemantic proximity Read ↗

Heterogeneity of <i>MYCN</i> amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasisSemantic proximity Read ↗

Influence of neuroblastoma stage on serum‐based detection of <i>MYCN</i> amplificationSemantic proximity Read ↗

Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients.Semantic proximity Read ↗

The <i>MYCN</i> Enigma: Significance of <i>MYCN</i> Expression in NeuroblastomaSemantic proximity Read ↗

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group studySemantic proximity Read ↗

MYCN Fish combined with immunohistochemistry is a more prognostic factor for neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.